Molbio Diagnostics, a leading point-of-care molecular diagnostics company, is set to launch its initial public offering (IPO) on August 10, 2026, with a price band of Rs 768 to Rs 807 per share. The IPO, which will remain open for subscription until August 12, 2026, is expected to raise approximately Rs 939.70 crore.